ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

15 Health Benefits of Chia Seeds, According to Science

Natural Remedies for the Prevention of Dry Eyes

Tangerine Oil: A Citrusy Essential Oil With Well-Rounded Uses

Magnesium Deficiency Raises Your Risk of Many Chronic Ailments

Resveratrol supplementation improves arterial stiffness in type 2 diabetics

What Makes Spanish Marjoram Oil Special?

CoQ10's Potential Capabilities for Your Health

How Can Melatonin Benefit You?

Cloves: Boost Your Immune System the Sweet and Spicy Way

8 Chia Seed Recipes

 
Print Page
Email Article

‘Lipkin’ ME/CFS Virus Report Embargo to End at 12:01 AM, Sep 18

  [ 13 votes ]   [ Discuss This Article ]
www.ProHealth.com • September 10, 2012


Sep 16 Update: A post on XMRV Global Action's Facebook site has reported a notice from the CFIDS Assoc. indicating that the findings of the study of virus involvement in ME/CFS patient samples, led by Columbia University 'virus hunter' Ian Lipkin, MD, will be released in the wee hours, at 12:01 AM Eastern Time Tuesday Sep 18 (9:01 PM Sep 17, Pacific Time). It will be published by the open access journal mBio (http://mBio.asm.org).

Also preceding the planned Tuesday morning Columbia press conference described below, Dr. Lipkin will discuss the study results in a special episode of the netcast that colleague Dr. Vicent Racaniello hosts - "This Week in Virology" - to begin at 12:01 AM Eastern Time (http://www.twiv.tv).

_____________________________________

Apparently the press event that Columbia announced last week...

...will still be streamed live starting at 10:30 AM Eastern Time (7:30 AM Pacific) on Tuesday, September 18, according to Columbia's Center for Infection and Immunity (CII).

The live press conference will be found on the CII website (www.cii.columbia.edu).

See the full announcement of this press event below.

__________________________

CII Press Conference September 18th, 2012
10:30 AM (EDT) and 7:30 AM Pacific Time


“Multicenter Study on Chronic Fatigue Syndrome/Myalgic Encephalomyelitis”

The causes of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) have long eluded scientists. In 2009/2010, two high-profile papers linked the syndrome to infection with a mouse retrovirus called XMRV (xenotropic murine leukemia virus (MLV)-related virus) and murine retrovirus-like sequences (designated pMLV: polytropic MLV). Given that affected patients often have symptoms consistent with a chronic infection, this viral connection was deemed plausible, and the findings were celebrated as a major achievement for a complex disease that afflicts nearly 1 million in the U.S.

However, follow-up investigations by several laboratories were unable to detect XMRV or pMLV in CFS patients.

To definitively resolve this issue, the National Institute of Allergy and Infectious Diseases commissioned a large-scale, multicenter study under the auspices of the Center for Infection and Immunity at Columbia University’s Mailman School of Public Health, in partnership with the Centers for Disease Control and Prevention, the Food and Drug Administration, the NIH’s National Cancer Institute and Warren G. Magnuson Clinical Center, and others (see full list below).

Investigators from the multicenter study on CFS/ME and XMRV/pMLV will discuss their findings and future directions. A live video will be posted below [CII blog page - http://cii.columbia.edu/blog.htm?cid=tM5E7V?].

For attendance at the event, members of the media should RSVP by 9:00 AM on Monday, Sept. 17th to Nsikan Akpan (212-342-9051 | nea2107@columbia.edu) or Stephanie Berger, Mailman School of Public Health (212-305-4372 | sb2247@columbia.edu).

WHEN: Tuesday, September 18, 2012
            Press Conference begins at 10:30 AM (EDT)

WHO: W. Ian Lipkin, MD (Moderator)
Center for Infection and Immunity (CII), Mailman School of Public Health, Columbia University
• Principal Investigator and Director of Center for Infection and Immunity
• John Snow Professor of Epidemiology
• Professor of Neurology and Pathology
 
Harvey Alter, MD
National Institutes of Health, Department of Transfusion Medicine
• Distinguished NIH Investigator
• Chief, Clinical Studies
• Associate Director of Research
 
Mady Hornig, MD
Center for Infection and Immunity, Mailman School of Public Health, Columbia University
• Director of Translational Research at CII
• Associate Professor of Epidemiology

Judy Mikovits, PhD
Mikovits Consulting
 
Francis Ruscetti, PhD
National Cancer Institute, Frederick National Laboratory for Cancer Research
• Head, Leukocyte Biology Section
• Senior Investigator

Collaborating Research Groups:

Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD.

Mikovits Consulting, Oxnard, CA.

Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA.

Cancer and Inflammation Program, Frederick National Laboratory for Cancer Research, Frederick, MD.

Tissue Safety Laboratory, Office of Cellular, Tissue and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD.

Nova Southeastern University, Fort Lauderdale FL.

Miami Veterans Affairs Medical Center, Miami, FL.

Brigham and Women’s Hospital, Boston, MA.

Infectious Disease Clinic, Stanford University, Palo Alto, CA.

Fatigue Consultation Clinic, Salt Lake City, UT.

Levine Clinic, New York, NY.

Simmaron Research Institute, Incline Village, NV.

Department of Biostatistics, Columbia University, New York, NY.

Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY.

Center for Infection and Immunity, Columbia University, New York, NY.

Department of Molecular Biology and Microbiology, Tufts University, Boston, MA.




Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil Ultra ATP+, Double Strength Optimized Curcumin Longvida®


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Nutrients to Combat the Modern Stress Epidemic Nutrients to Combat the Modern Stress Epidemic
Anti-Inflammatory Properties of Tart Cherry Anti-Inflammatory Properties of Tart Cherry
Natural Relief for Soreness, Pain and Swelling - Putting Out the Fire Natural Relief for Soreness, Pain and Swelling - Putting Out the Fire
Guarding Against the Dangers of Vitamin D Deficiency Guarding Against the Dangers of Vitamin D Deficiency
Red Yeast Rice - Natural Option for Supporting Healthy Cholesterol Red Yeast Rice - Natural Option for Supporting Healthy Cholesterol

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map